calendar

3 catalysts · 1 drug expiry · 1 patent expiry · 1 phase iv trial initiation

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

TA: pulmonology×to 2026-04-24×clear all

type

drug expiry1
patent expiry1
phase iv trial initiation1

therapy area

Oncology9
Infectious Disease5
Dermatology4

Week of Apr 20, 2026

›Apr 24, 2026patent expiry109d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

full page →laninamivir →source: globaldata

›Apr 24, 2026drug expiry109d agoDaiichi Sankyo Co Ltd — laninamivir (Drug Expiry (Japan))laninamivir

Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

full page →laninamivir →source: globaldata

›Apr 24, 2026phase iv trial initiation109d agoPeople's College of Medical Sciences & Research Centre — formoterol (Phase IV Trial Initiation)formoterol

Therapy area: Respiratory. Indication: Chronic Obstructive Pulmonary Disease (COPD)

full page →formoterol →source: globaldata